WGS Q3'26 Earnings: revenue estimate is 122.93M USD

What happened

GeneDx Holdings Corp. (WGS) is scheduled to report its third-quarter 2026 results on November 9, after the market closes, with disclosure expected at 4:00 p.m. ET. The supplied estimate is revenue of 122.93 million USD and earnings per share of 0.07 USD.

Confirmed

Global impact / market context

The figures are estimates, not reported results, so they do not yet show how much GeneDx actually earned or whether revenue grew. When results arrive, differences from these estimates could change investor expectations for the company’s sales and profit per share.

Analyst inference

The article lists reported revenue and earnings per share for earlier quarters, while Q3 2026 results remain blank. This makes the upcoming report the point when investors can compare actual performance with the stated forecasts; no market reaction is provided.

Analyst inference

What to watch

1. Check the report after the scheduled November 9 release for actual revenue and earnings per share, then compare both figures with the supplied estimates. Analyst inference
2. Watch whether reported revenue of 122.93 million USD and earnings per share of 0.07 USD are confirmed or differ from the estimates. Analyst inference
3. Look for company explanations of sales and costs in the results; the article gives no business drivers or guidance that could explain future performance. Analyst inference

Evidence

• Original source link unavailable